Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.19.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]    
Sales $ 3,099,608 $ 1,817,302
Cost of sales (1,441,696) (1,946,900)
Gross profit (loss) 1,657,912 (129,598)
Operating Expenses    
Selling and marketing 317,404 347,808
General and administrative 6,423,540 7,014,919
Depreciation and amortization 171,749 193,065
Total operating expenses 6,912,693 7,555,792
Loss from Operations (5,254,781) (7,685,390)
Other Expense (Income)    
Interest expense 611,297 320,571
Gain on sale of investment in subsidiary 199,200
Gain on foreign currency translation 187,660
Total other expense 423,637 121,371
Loss from Continuing Operations (5,678,418) (7,806,761)
Loss from Discontinued Operations (105,751)
Net Loss (5,678,418) (7,912,512)
Series B preferred stock dividends (724,108) (345,079)
Net Loss Attributable to Common Stockholders $ (6,402,526) $ (8,257,591)
Net Loss per Basic and Diluted Common Share:    
Loss from continuing operations $ (0.14) $ (0.19)
Loss from discontinued operations
Net Loss per Common Share $ (0.14) $ (0.19)
Weighted Average Number of Common Shares Outstanding:    
Basic and Diluted 44,889,732 42,996,124